Nekkanti, Naresh
Nekkanti, Naresh was paid $780K by Medicaid between Jan 2018 and Dec 2024, across 11 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 53% of everything it billed.
33Billing provider infoNEKKANTI, NARESH
MATTOON, IL 61938
MATTOON, IL 61938
33aNPI1366762759assigned 06/08/2010
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$780K
24GClaims15,807
24DCodes billed11
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Student in an Organized Health Care Education/Training Program providers in Illinois
Rank by total paid#21 of 981
Median peer was paid$27K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 974 | $36K | |
| 2019 | 1,656 | $70K | |
| 2020 | 1,661 | $78K | |
| 2021 | 2,886 | $136K | |
| 2022 | 2,752 | $139K | |
| 2023 | 3,173 | $154K | |
| 2024incomplete | 2,705 | $169K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 53% | 9,265 | 8,507 | $415K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 4,428 | 3,899 | $307K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.4% | 272 | 234 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 1,172 | 1,094 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 271 | 228 | $14K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 148 | 140 | $5K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | <1% | 38 | 38 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 60 | 45 | $565.74 |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | <1% | 12 | 12 | $308.00 |
| 81002 | <1% | 108 | 96 | $267.80 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 33 | 28 | $117.85 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.